These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 16084308)

  • 1. The role of enteric microflora in inflammatory bowel disease: human and animal studies with probiotics and prebiotics.
    Rioux KP; Madsen KL; Fedorak RN
    Gastroenterol Clin North Am; 2005 Sep; 34(3):465-82, ix. PubMed ID: 16084308
    [No Abstract]   [Full Text] [Related]  

  • 2. Probiotics and inflammatory bowel diseases.
    Bai AP; Ouyang Q
    Postgrad Med J; 2006 Jun; 82(968):376-82. PubMed ID: 16754706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microbes, intestinal inflammation and probiotics.
    Khan MW; Kale AA; Bere P; Vajjala S; Gounaris E; Pakanati KC
    Expert Rev Gastroenterol Hepatol; 2012 Feb; 6(1):81-94. PubMed ID: 22149584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Probiotics and prebiotics for the treatment of inflammatory bowel disease].
    Mitsuyama K
    Nihon Rinsho; 2005 May; 63(5):850-8. PubMed ID: 15881181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic impact of manipulating microbiota in inflammatory bowel disease.
    Kanauchi O; Mitsuyama K; Andoh A
    Curr Pharm Des; 2009; 15(18):2074-86. PubMed ID: 19519445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management].
    Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A
    Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Probiotics for inflammatory bowel disease].
    Iizuka H; Takaishi H; Hibi T
    Nihon Rinsho; 2005 May; 63(5):776-80. PubMed ID: 15881169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VSL#3: an analysis of basic and clinical contributions in probiotic therapeutics.
    Gionchetti P; Lammers KM; Rizzello F; Campieri M
    Gastroenterol Clin North Am; 2005 Sep; 34(3):499-513, ix-x. PubMed ID: 16084310
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunology. Therapeutic manipulation of gut flora.
    Shanahan F
    Science; 2000 Aug; 289(5483):1311-2. PubMed ID: 10979858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
    Yu CG; Huang Q
    J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials.
    Hedin C; Whelan K; Lindsay JO
    Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probiotics and their derivatives as treatments for inflammatory bowel disease.
    Prisciandaro L; Geier M; Butler R; Cummins A; Howarth G
    Inflamm Bowel Dis; 2009 Dec; 15(12):1906-14. PubMed ID: 19373788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Probiotics in inflammatory bowel disease: is it all gut flora modulation?
    Ghosh S; van Heel D; Playford RJ
    Gut; 2004 May; 53(5):620-2. PubMed ID: 15082574
    [No Abstract]   [Full Text] [Related]  

  • 14. Host-flora interactions in inflammatory bowel disease.
    Shanahan F
    Inflamm Bowel Dis; 2004 Feb; 10 Suppl 1():S16-24. PubMed ID: 15168825
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation?
    Verbeke KA; Boesmans L; Boets E
    Proc Nutr Soc; 2014 Nov; 73(4):490-7. PubMed ID: 24969143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of probiotics on intestinal barrier function.
    Mennigen R; Bruewer M
    Ann N Y Acad Sci; 2009 May; 1165():183-9. PubMed ID: 19538305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gut microflora: a new target for therapeutic approaches in inflammatory bowel disease.
    Mitsuyama K; Sata M
    Expert Opin Ther Targets; 2008 Mar; 12(3):301-12. PubMed ID: 18269340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of probiotic action: Implications for therapeutic applications in inflammatory bowel diseases.
    Vanderpool C; Yan F; Polk DB
    Inflamm Bowel Dis; 2008 Nov; 14(11):1585-96. PubMed ID: 18623173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiotics in inflammatory bowel diseases.
    Guarner F
    Br J Nutr; 2007 Oct; 98 Suppl 1():S85-9. PubMed ID: 17922967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting intestinal microflora in inflammatory bowel disease.
    Guslandi M
    World J Gastroenterol; 2006 Nov; 12(44):7225-6. PubMed ID: 17131494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.